Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Dova Pharmaceuticals, Inc.

Oncology Briefings™: Update for Nurses on Novel Treatment and Management of ITP

Release Date: November 15, 2021
Expiration Date: November 15, 2022

Activity Overview

This online activity is designed to provide a concise and focused overview of the diagnosis and management of idiopathic thrombocytopenia purpura (ITP). It includes the latest data for available therapies, with focus on thrombopoietin receptor agonists (TPO-RAs) and spleen tyrosine-protein kinase (SYK) inhibitors. The engaging, multimedia format of this program includes audio commentary from an expert thought leader integrated with text-based elements.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Dova Pharmaceuticals, Inc.

Instructions for This Activity and Receiving Credit

Complete the activity (including pre- and post-activity assessments).
Answer the evaluation questions.
Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This educational activity is directed toward advanced practitioners, nurses, and other health care professionals interested in the multidisciplinary treatment and management of ITP.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

Discuss the pathophysiology and criteria for ITP diagnosis and treatment initiation.
Assess updated efficacy and safety profiles of evolving therapeutic approaches for the treatment of ITP.
Execute strategies in order to monitor and mitigate the negative impact of treatment-associated toxicities throughout the ITP. disease course
Implement nursing strategies to optimize treatment for patients with ITP with a focus on patient counseling for supportive care and management of therapy-related toxicities.

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource^®, LLC have no relevant financial relationships with ineligible companies.

Faculty

Ilene C. Weitz, MD
Professor of Clinical Medicine
Jane Anne Nohl Division of Hematology
Keck School of Medicine
University of Southern California
Los Angeles, CA

Disclosures: Ilene C. Weitz, MD, has no relevant financial relationships with ineligible companies.

PER^® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.